• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » EAG acquires ABC Laboratories

EAG acquires ABC Laboratories

July 24, 2015
CenterWatch Staff

Evans Analytical Group (EAG), a fully integrated, independent laboratory network based in Boston, has acquired Analytical Bio-Chemistry Laboratories, of Columbia, Mo. (ABC Laboratories). EAG is a private company, majority owned by Odyssey Investment Partners.  Financial terms of the transaction have not been disclosed.

ABC is a CRO providing product development and analytical testing services for the agrochemical and pharma/biopharma markets. The company offers a complete range of agricultural product development and GLP-compliant environmental testing services for the agrochemical industry through its Environmental Services division, as well as a comprehensive suite of development and CGMP and GLP-compliant testing capabilities for small and large molecule therapies and medical devices through its Pharmaceutical Services division.

Over the last three years, the ChemEco division of EAG has become the preeminent global provider of analytical and testing services for its clients in agrochemicals, pharmaceuticals and industrial chemicals markets. With the ever-increasing pace of new regulations implemented to safeguard the food and environment around the world, the U.S. EPA and its global counterparts expect a set of comprehensive scientific studies before a chemical is registered for broad use. The acquisition of ABC strengthens EAG’s existing laboratories in the U.S. and Europe and further enhances its leadership in this market of growing importance.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing